Tuesday, 30 April 2024 12:54 AM
OR
Login using
DDA mulls recalling or banning Valsartan drugs
January 15, 2019 07:59 am
KATHMANDU, Jan 15: The Department of Drug Administration (DDA), the apex drugs regulating body, has started discussing how to control the controversial Valsartan drugs, which are used by hypertension and heart patients. The authority is discussing whether to recall the drugs or ban them altogether.
Trending
Just In
- Nepal and Vietnam could collaborate in promotion of agriculture and tourism business: DPM Shrestha
- Govt urges entrepreneurs to invest in IT sector to reap maximum benefits
- Chinese company Xiamen investing Rs 3 billion in assembling plant of electric vehicles in Nepal
- NEPSE inches up 0.07 points, while daily turnover inclines to Rs 2.95 billion
- Gandaki Province reports cases of forest fire at 467 locations
- Home ministry introduces online pass system to enter Singha Durbar
- MoLESS launches ‘Shramadhan Call Center’ to promptly address labor and employment issues
- Biratnagar High Court orders Krishna Das Giri to appear before court within one month in disciple rape case